ASX
Telix Pharmaceuticals Limited
TLX:ASX•Healthcare
Sensitive ASX Announcement
First Australian Patient Dosed in ZIRCON Phase III Trial
Published: 20/08/19, 01:42pm (AEST)•3 pages